Pills masthead

Fundamentals

Select the financial statements you wish to view below.  The reports below may be viewed on either an annual or quarterly basis.

NYSELCI
All numbers in thousands USD
Period Ending
Mar 31, 2022
Dec 31, 2021
Sep 30, 2021
Jun 30, 2021
Total Revenue
78,357
86,508
101,525
106,009
Cost of Revenue
75,279
80,798
85,004
83,350
Gross Profit
3,078
5,710
16,521
22,659
Operating Expenses
Research Development
5,807
4,747
5,764
6,017
Selling General and Administrative
17,572
18,791
18,905
21,576
Non Recurring
--
--
--
--
Others
0
0
0
0
Total Operating Expenses
23,379
23,538
24,669
27,593
Operating Income or Loss
(20,301)
(17,828)
(8,148)
(4,934)
Income from Continuing Operations
Total Other Income/Expenses Net
(1,445)
(50,195)
(28)
(30,510)
Earnings Before Interest And Taxes
(21,746)
(68,023)
(8,176)
(35,444)
Interest Expense
14,517
14,430
14,224
13,217
Income Before Tax
(36,263)
(82,453)
(22,400)
(48,661)
Income Tax Expense
(1,365)
(1,368)
(58)
129,225
Minority Interest
--
--
--
--
Net Income From Continuing Ops
(34,898)
(81,085)
(22,342)
(177,886)
Non-recurring Events
Discontinued Operations
--
--
--
--
Extraordinary Items
--
--
--
--
Effect Of Accounting Changes
--
--
--
--
Other Items
0
0
0
0
Net Income
(34,898)
(81,085)
(22,342)
(177,886)
Preferred Stock And Other Adjustments
--
--
--
--
Net Income Applicable To Common Shares
(34,898)
(81,085)
(22,342)
(177,886)